Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
Use of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce - EDM Research Series No. 016
(1995; 156 pages) Voir le document au format PDF
Table des matières
Afficher le documentACKNOWLEDGMENTS
Afficher le documentPREFACE
Afficher le documentEXECUTIVE SUMMARY
Ouvrir ce répertoire et afficher son contenu1. INTRODUCTION
Afficher le document2. RATIONALE AND OBJECTIVE OF THE ASSESSMENT
Afficher le document3. ACTIVITIES UNDERTAKEN: Preparations and Method of Work
Ouvrir ce répertoire et afficher son contenu4. ANALYSIS OF RESULTS FROM IMPORTING COUNTRIES
Ouvrir ce répertoire et afficher son contenu5. ANALYSIS OF RESULTS FROM EXPORTING COUNTRIES
Afficher le document6. ANALYSIS OF RESULTS FROM INTERNATIONAL SUPPLY AGENCIES
Ouvrir ce répertoire et afficher son contenu7. SUMMARY ANALYSIS
Afficher le document8. CONCLUSIONS
Afficher le documentANNEX 1: Resolution adopted by the Twenty-second World Health Assembly
Afficher le documentANNEX 2 (a): Resolution Adopted by the Twenty-Eighth World Health Assembly
Afficher le documentANNEX 2 (b): Certificate of Pharmaceutical Product(S)1
Afficher le documentANNEX 3 (a): Resolution adopted by the Forty-first World Health Assembly
Afficher le documentANNEX 3 (b): Certificate of Pharmaceutical Product(s)1 (Proposed Layout)
Afficher le documentANNEX 4 (a): Proposed Guidelines on the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce
Afficher le documentANNEX 4 (b): Certificate of a Pharmaceutical Product
Afficher le documentANNEX 4 (c): Statement of Licensing Status of Pharmaceutical Product(s) Model Statement of Licensing Status of Pharmaceutical Product(s)
Afficher le documentANNEX 4 (d): Manufacturer’s/Official Batch Certificate of a Pharmaceutical Product
Afficher le documentANNEX 5: Protocol for the Assessment of the Use of the WHO Certification Scheme by Importing Country
Afficher le documentANNEX 6: List of Participants in the Study
Afficher le documentANNEX 7: Protocol for the Assessment of the Use of the WHO Certification Scheme by Exporting Country
Afficher le documentANNEX 8: Protocol for the Assessment of the Use of the WHO Certification Scheme in an International Supply Organization
Afficher le documentANNEX 9: Study Instrument for Assessment of the WHO Certification Scheme by Importing Country
Ouvrir ce répertoire et afficher son contenuANNEX 10: Summaries of Mission Reports on the Assessment of the Use of the WHO Certification Scheme
Afficher le documentBACK COVER
 

ANNEX 6: List of Participants in the Study

A. IMPORTING COUNTRIES

1. Regional Office for Africa (AFRO)

1.1 Local Team Members

BENIN: Monsieur Eugène Déguénon, Pharmacien, Directeur des Pharmacies et des Laboratoires, Ministère de la Santé publique, Boîte postale 882, Cotonou

Mr Adolphe Topanou, Pharmacien, Conseiller Technique, Ministère de la Santé publique, Boîte postale 882, Cotonou

CAMEROON: M. Nguele Ze, Pharmacien, Chef Service Inspection Visas et Informations pharmaceutiques, c/o M. le Représentant de l'OMS, Yaoundé

M. Ndo Jean Rollin Bertrand, Pharmacien, Chef Service provincial Pharmacie du Littoral et Chef Transit Santé, c/o M. le Représentant de l'OMS, Yaoundé

CENTRAL AFRICAN REPUBLIC: Mr Jacob Ngaba, Inspecteur des Services pharmaceutiques, Ministère de la Santé publique, Boîte postale 883, Bangui

Mr David Kilayo, Chef de service de la pharmacie et du médicament, Ministère de la Santé publique, Boîte postale 883, Bangui

KENYA: Dr K. Baya, Ministry of Health, P.O. Box 30016, Nairobi

Dr E. Kamamia, Ministry of Health, P.O. Box 30016, Nairobi

MALAWI: Mr P.S.P. Tembo, Chief Pharmacist and Registrar, Pharmacy Medicines and Poisons Board, Ministry of Health, P.O. Box 30390, Capital Hill, Capital City, Lilongwe 3

Mr W.C. Chalira, Chief Pharmacist, Central Medical Stores, Ministry of Health, P.O. Box 30390, Capital Hill, Capital City, Lilongwe 3

TANZANIA: Mr J.S. Muhume, Pharmacist, Central Medical Stores, Ministry of Health and Social Welfare, P.O. Box 9083, Dar-es-Salaam

Mr L.R. Mhangwa, Pharmacy Board, Ministry of Health and Social Welfare, P.O. Box 9083, Dar-es-Salaam

1.2 International Temporary Advisers

BENIN: Mr Pascal Coffi Hessou*, Central d'Achat des Médicaments essentiels, B.P. 01 3280, Cotonou

BURUNDI: Mr Anaclet Baza*, c/o Monsieur le Représentant de l'OMS, Boîte postale 1450, Bujumbura

* Mission to, Benin, Cameroon and Central African Republic

ETHIOPIA: Mr Eshetu Wondemagegnehu**, P.O. Box 30635, Addis Ababa

ZIMBABWE: Mr Aidan Chidarikire**, Director of Pharmacy Services in Zimbabwe, Ministry of Health and Child Welfare, P.O. Box CY 1122, Causeway, Harare

** Mission to Kenya, Malawi and Tanzania

2. Regional Office for the Americas (AMRO)

2.1. Local Team Members

ECUADOR: Dra Elvira Marchan, Directora de Registro y Control Medicamentos, Ministerio de Salud, Pública, Juan Larrea 444 y Riofrío, Quito

Dr Frederico Santos, Ministerio de Salud Pública, Juan Larrea 444 y Riofrío, Quito

JAMAICA: Ms Grace Allen, Director, Pharmaceutical Services, Ministry of Health, P.O. Box 472, Kingston 5

Mrs Henry, Jamaica Commodity Trading Company, Ministry of Health, P.O. Box 472, Kingston 5

2.2 International Temporary Advisers

ARGENTINA: Dr Marcelo Vernengo***, Rep. Arabe Siria 2711-5° Piso (ex Malabia), 1425 Buenos Aires

UNITED STATES OF AMERICA: Mr E. Rivera Martinez***, Centre for Drug Evaluation and Research, Food and Drug Administration, 5600 Fishers Lane, RM-A-32, Rockville, MA 20852

*** Mission to Ecuador and Jamaica

3. Regional Office for the Eastern Mediterranean (EMRO)

3.1 Local Team Members

TUNISIA: Dr Iddir Kameleddine, Inspecteur Divisionnaire, Sous-Directeur à la Direction de la Pharmacie et du Médicament, Ministère de la Santé publique, Place Bab Sadoun, Tunis

Dr Jaleleddine Hila, Directeur de l'Approvisionnement à la Pharmacie centrale de la Tunisie, Ministère de la Santé publique, Place Bab Sadoun, Tunis

YEMEN: Dr Mohamed Said Shaibani, c/o The WHO Representative, P.O. Box 543,

Sana'a Dr Hussein Al-Kataa, c/o The WHO Representative, P.O. Box 543, Sana'a

3.2 International Temporary Advisers

CYPRUS: Mr E. Kkolos*, Director, Pharmaceutical Services, Ministry of Health, Nicosia

FRANCE: Mr Patrick Becu**, Inspection de la Pharmacie, Direction régionale des affaires sanitaires et sociales, 52, rue Daire, 80037 Amiens Cedex 1

* Mission to Yemen
** Mission to Tunisia

4. Regional Office for South-East Asia (SEARO)

4.1 Local Team Members

MYANMAR: Mr U Myint Thein, Principal, Institute of Pharmacy, Ministry of Health of the Union of Myanmar, International Health Division, Yangon

Dr Maw Thein, Deputy Director, Central Medical Stores Department, Ministry of Health of the Union of Myanmar, International Health Division, Yangon

SRI LANKA: Dr S. Tennakoon, Deputy Director General (Laboratory Services), c/o The WHO Representative, Colombo 4

Mr Hsk Sirisena, Manager, Products and Planning, State Pharmaceuticals Corporation, c/o The WHO Representative, Colombo 4

4.2 International Temporary Advisers

POLAND: Dr W. Wieniawski***, Institute of Drug Control, Chelmska 3000-725 Warsaw

SINGAPORE: Ms Amy Lim***, Deputy Director, Drug Administration Division, Ministry of Health, College of Medicine Building, 16 College Road, Singapore 0316

*** Mission to Myanmar and Sri Lanka

5. Regional Office for the Western Pacific (WPRO)

5.1 Local Team Members

FIJI: Mr Murray Patterson, Chief Pharmacist, c/o The WHO Representative, P.O. Box 113, Suva

MALAYSIA: Dr Hadida Bte Hashim, c/o Ministry of Health, Kuala Lumpur 50590

PAPUA NEW GUINEA: Mr D. Gwillim, a/Superintendent, Pharmaceutical Supplies, Ministry of Foreign Affairs, c/o The WHO Representative, P.O. Box 5896, Boroko, N.C.D., Port-Moresby

Mrs D. Tuka, Secretary, Pharmaceutical Supply and Tender Board, Ministry of Foreign Affairs, c/o The WHO Representative, P.O. Box 5896, Boroko, N.C.D., Port-Moresby

5.2 International Temporary Advisers

POLAND: Dr W. Wieniawski*, Institute of Drug Control, Chelmska 3000-725 Warsaw

SINGAPORE: Mr Yip Lung Wong**, 40 Windsor Park Road, Singapore 2057

INDIA: Dr Prem Gupta***, Flat No. 95, Pocket B, Sukhdev Vihar, New Delhi 110025

* Mission to Fiji, Malaysia, Papua New Guinea and Philippines
** Mission to Papua New Guinea
*** Mission to Malaysia

B. EXPORTING COUNTRIES

1. FRANCE

Dr Iddir Kameleddine, Inspecteur Divisionnaire, Sous-Directeur à la Direction de la Pharmacie et du Médicament, Ministère de la Santé publique, Place Bab Sadoun, Tunis

2. INDIA

Mr Yeap Boon Chye, 40 Jalan 14/48, 46100 Petaling Jaya, Selangou Darul Ehsan, Malaysia

Ms Amy Lim, Deputy Director, Drug Administration, Ministry of Health, College of Medicine Building, 16 College Road, Singapore 0316

C. INTERNATIONAL SUPPLY AGENCIES

1. International Dispensary Association (IDA)

Dr W. Wieniawski*, Institute of Drug Control, Chelmska 30, 00-725 Warsaw, Poland

* Team Leader

Mr Patrick Becu, Inspection de la Pharmacie, Direction régionale des Affaires sanitaires et sociales, 52, rue Daire, 80037 Amiens Cedex 1, France

2. United Nations Children’s Fund (UNICEF)

Dr W. Wieniawski*, Institute of Drug Control, Chelmska 3000-725 Warsaw, Poland

Mr Patrick Becu, Inspection de la Pharmacie, Direction régionale des Affaires sanitaires et sociales, 52, rue Daire, 80037 Amiens Cedex 1, France

 

vers la section précédente
vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019